2
|
Li Q, Yuan M, Li X, Li J, Xu M, Wei D, Wu D, Wan J, Mei S, Cui T, Wang J, Zhu Z. New dammarane-type triterpenoid saponins from Panax notoginseng saponins. J Ginseng Res 2020; 44:673-679. [PMID: 32913396 PMCID: PMC7471129 DOI: 10.1016/j.jgr.2018.12.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Revised: 12/04/2018] [Accepted: 12/06/2018] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Panax notoginseng saponin (PNS) is the extraction from the roots and rhizomes of Panax notoginseng (Burk.) F. H. Chen. PNS is the main bioactive component of Xuesaitong, Xueshuantong, and other Chinese patent medicines, which are all bestselling prescriptions in China to treat cardiocerebrovascular diseases. Notoginsenoside R1 and ginsenoside Rg1, Rd, Re, and Rb1 are the principal effective constituents of PNS, but a systematic research on the rare saponin compositions has not been conducted. OBJECTIVE The objective of this study was to conduct a systematic chemical study on PNS and establish the HPLC fingerprint of PNS to provide scientific evidence in quality control. In addition, the cytotoxicity of the new compounds was tested. METHODS Pure saponins from PNS were isolated by means of many chromatographic methods, and their structures were determined by extensive analyses of NMR and HR-ESI-MS studies. The fingerprint was established by HPLC-UV method. The cytotoxicity of the compounds was tested by 3-(4,5-dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide assay. RESULTS AND CONCLUSION Three new triterpenoid saponins (1-3) together with 25 known rare saponins (4-28) were isolated from PNS, except for the five main compounds (notoginsenoside R1 and ginsenoside Rg1, Rd, Re, and Rb1). In addition, the HPLC fingerprint of PNS was established, and the peaks of the isolated compounds were marked. The study of chemical constituents and fingerprint was useful for the quality control of PNS. The study on antitumor activities showed that new Compound 2 exhibited significant inhibitory activity against the tested cell lines.
Collapse
Affiliation(s)
- Qian Li
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Mingrui Yuan
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Xiaohui Li
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Jinyu Li
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Ming Xu
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Di Wei
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Desong Wu
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Jinfu Wan
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Shuangxi Mei
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Tao Cui
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Jingkun Wang
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| | - Zhaoyun Zhu
- Yunnan Institute of Materia Medica, Kunming, China
- Innovation and R&D Center, Yunnan Bai Yao Group, Kunming, China
- Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, China
| |
Collapse
|
3
|
Susan Treesa GS, Neetha M, Saranya S, Anilkumar G. Cobalt‐Catalyzed Multi‐Component Reactions: Recent Advances and Perspectives in Organic Synthesis. ChemistrySelect 2020. [DOI: 10.1002/slct.202002021] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- G. S. Susan Treesa
- School of Chemical Sciences Mahatma Gandhi University Priyadarsini Hills, Kottayam Kerala India 686560
| | - Mohan Neetha
- School of Chemical Sciences Mahatma Gandhi University Priyadarsini Hills, Kottayam Kerala India 686560
| | - Salim Saranya
- School of Chemical Sciences Mahatma Gandhi University Priyadarsini Hills, Kottayam Kerala India 686560
| | - Gopinathan Anilkumar
- School of Chemical Sciences Mahatma Gandhi University Priyadarsini Hills, Kottayam Kerala India 686560
| |
Collapse
|